Estrogen-mediated mitigation of cardiac oxidative stress in ovariectomized rats is associated with upregulated cardiac circadian clock Per2 and heart-specific miRNAs.


Journal

Life sciences
ISSN: 1879-0631
Titre abrégé: Life Sci
Pays: Netherlands
ID NLM: 0375521

Informations de publication

Date de publication:
15 Oct 2023
Historique:
received: 22 05 2023
revised: 16 08 2023
accepted: 21 08 2023
pmc-release: 15 10 2024
medline: 25 9 2023
pubmed: 25 8 2023
entrez: 24 8 2023
Statut: ppublish

Résumé

Estrogen (E2) confers cardioprotection in premenopausal women and in models of menopause and its effects, mostly studied in female reproductive organs, vary on a circadian rhythm basis in relation to the circadian clock genes. However, it remains unknown if a similar circadian pattern exists in the female heart in a manner that explains, at least partly, the cardioprotective effect of E2. The aim of the present investigation was to determine if upregulation of the circadian clock Per2 and its regulated heart-specific miRNAs, and redox enzymes contribute to the E2-mediated cardioprotection in ovariectomized rats. Rats were subjected to ovariectomy (OVX) 2-weeks prior to a 2-week E2 treatment. On the last treatment day, hearts were collected every 4 h. for ex-vivo biochemical measurements. In parallel studies, telemetric mean arterial pressure (MAP) was obtained at the tissue collection times. OVX + E2 rats exhibited lower body weight during daytime and MAP during day and night times, and their hearts exhibited: (1) higher Per2 protein abundance, cardioprotective miRNAs (miRNA1, miRNA133a, miRNA208a, miRNA499), mALDH2, and catalase; (2) lower reactive oxygen species, cardio-detrimental miRNA652, carbonyl, MDA and HO-1 levels. The reciprocal Per2/HO-1 relationship was more evident during the daytime and correlated with the upregulated cardioprotective miRNAs in OVX + E2 rats. Finally, cardiac Per2, heart-specific miRNAs and reactive oxygen species levels and redox enzymes activities were similar in normal female and OVX + E2 rats. Enhancement of cardiac Per2, redox enzymes and heart-specific miRNAs likely contribute to E2-mediated mitigation of cardiac oxidative stress in OVX rats.

Identifiants

pubmed: 37619835
pii: S0024-3205(23)00673-2
doi: 10.1016/j.lfs.2023.122038
pmc: PMC10528738
mid: NIHMS1928822
pii:
doi:

Substances chimiques

Reactive Oxygen Species 0
MicroRNAs 0
Estrogens 0
Estradiol 4TI98Z838E
MIRN499 microRNA, human 0
Per2 protein, rat 0
Period Circadian Proteins 0
MIRN1 microRNA, rat 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

122038

Subventions

Organisme : NIAAA NIH HHS
ID : R01 AA014441
Pays : United States

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no conflict of interest.

Références

Endocr Rev. 2018 Oct 1;39(5):664-675
pubmed: 29901737
Circ Cardiovasc Genet. 2011 Aug 1;4(4):446-54
pubmed: 21642241
Int J Biochem Cell Biol. 2013 Mar;45(3):667-71
pubmed: 23291353
Front Cardiovasc Med. 2021 Mar 19;8:592362
pubmed: 33816571
Int Z Vitaminforsch Beih. 1959;10:225-96
pubmed: 14398945
Am J Physiol. 1998 May;274(5):H1539-44
pubmed: 9612361
Cell Regen. 2021 Jun 1;10(1):14
pubmed: 34060005
Clin Sci (Lond). 2010 Apr 20;119(2):87-95
pubmed: 20218970
FASEB J. 2014 Dec;28(12):5097-110
pubmed: 25145628
Toxicol Appl Pharmacol. 2015 Sep 15;287(3):284-92
pubmed: 26111663
Mol Ther. 2022 Feb 2;30(2):947-962
pubmed: 34174444
Biol Reprod. 2006 Oct;75(4):624-32
pubmed: 16807384
Chronobiol Int. 2020 Jul;37(7):1048-1058
pubmed: 32633152
Neuron. 2007 Jun 7;54(5):813-29
pubmed: 17553428
Am J Hypertens. 2007 Oct;20(10):1045-50
pubmed: 17903686
Semin Cell Dev Biol. 2022 Jun;126:56-65
pubmed: 33975754
Front Pharmacol. 2016 Dec 21;7:510
pubmed: 28066255
Am J Physiol Heart Circ Physiol. 2006 Jan;290(1):H1-16
pubmed: 16373589
J Neurosci Res. 2005 Dec 1;82(5):622-30
pubmed: 16273538
Life Sci. 2020 Sep 15;257:118118
pubmed: 32702445
Front Immunol. 2021 Oct 26;12:740562
pubmed: 34764958
Eur J Pharmacol. 2012 Mar 15;679(1-3):95-100
pubmed: 22305881
J Pharmacol Exp Ther. 2011 Oct;339(1):267-74
pubmed: 21768222
Alcohol Clin Exp Res. 2020 Jan;44(1):45-55
pubmed: 31693194
Oxid Med Cell Longev. 2021 Jun 28;2021:5523516
pubmed: 34257804
Free Radic Biol Med. 2005 Jul 1;39(1):108-17
pubmed: 15925283
Life Sci. 2020 Jun 1;250:117598
pubmed: 32243927
Learn Mem. 2018 Apr 16;25(5):214-229
pubmed: 29661834
Adv Exp Med Biol. 2019;1193:1-33
pubmed: 31368095
Life Sci. 2017 Aug 1;182:41-49
pubmed: 28599865
Medicina (Kaunas). 2019 Aug 14;55(8):
pubmed: 31416275
Circulation. 1993 Oct;88(4 Pt 1):1999-2009
pubmed: 8403349
Trends Mol Med. 2008 Jun;14(6):254-60
pubmed: 18457996
Circ Res. 2013 Jul 19;113(3):322-6
pubmed: 23743335
Oxid Med Cell Longev. 2021 Oct 8;2021:6256399
pubmed: 34659637
Cell. 2008 Sep 5;134(5):728-42
pubmed: 18775307
Eur J Endocrinol. 2000 Mar;142(3):307-14
pubmed: 10700727
Am J Physiol Regul Integr Comp Physiol. 2010 Mar;298(3):R627-34
pubmed: 20053965
PLoS One. 2012;7(8):e44237
pubmed: 22952936
Mech Ageing Dev. 2017 Jun;164:41-48
pubmed: 28408140
Clin Exp Pharmacol Physiol. 2009 Oct;36(10):1002-9
pubmed: 19413598
J Mol Cell Cardiol. 1999 Aug;31(8):1527-37
pubmed: 10423350
Front Neurol. 2015 Jan 13;5:289
pubmed: 25628599
Mol Hum Reprod. 2003 Sep;9(9):503-7
pubmed: 12900508
FEBS J. 2009 Oct;276(19):5447-55
pubmed: 19682069
J Surg Res. 2018 Nov;231:366-372
pubmed: 30278955
Steroids. 2018 May;133:44-52
pubmed: 29180290
Circ Res. 2010 Mar 5;106(4):647-58
pubmed: 20203314
J Korean Med Sci. 1998 Jun;13(3):241-6
pubmed: 9681801
Hum Gene Ther. 2020 Jan;31(1-2):119-128
pubmed: 31822134
Endocr Rev. 2013 Jun;34(3):309-38
pubmed: 23460719
Am J Physiol Endocrinol Metab. 2008 Nov;295(5):E1025-31
pubmed: 18728223
Endocrinology. 2006 Aug;147(8):3769-76
pubmed: 16675517
Hum Mol Genet. 2011 Feb 15;20(4):731-51
pubmed: 21118894
Am J Physiol Regul Integr Comp Physiol. 2000 Nov;279(5):R1599-605
pubmed: 11049841
Biochem Biophys Res Commun. 2010 Jan 1;391(1):73-7
pubmed: 19896465
Circulation. 2009 May 5;119(17):2357-2366
pubmed: 19380620
J Clin Endocrinol Metab. 1998 Dec;83(12):4524-7
pubmed: 9851804
Hypertens Res. 2011 Apr;34(4):496-502
pubmed: 21248760
Methodist Debakey Cardiovasc J. 2017 Jan-Mar;13(1):4-8
pubmed: 28413575
Alcohol Clin Exp Res. 2014 May;38(5):1205-15
pubmed: 24754626
Alcohol. 2020 Dec;89:27-36
pubmed: 32777474
Ann Transl Med. 2021 Apr;9(8):654
pubmed: 33987352
J Cell Mol Med. 2019 Sep;23(9):6005-6016
pubmed: 31240830
Eur Heart J. 2010 Nov;31(22):2765-73
pubmed: 20534597
Am J Physiol Endocrinol Metab. 2014 Apr 1;306(7):E740-7
pubmed: 24368668

Auteurs

Syed Anees Ahmed (SA)

Department of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Greenville, NC 27834, United States of America.

Baohong Zhang (B)

Department of Biology, East Carolina University, Greenville, NC 27858, United States of America.

Abdel A Abdel-Rahman (AA)

Department of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Greenville, NC 27834, United States of America. Electronic address: abdelrahmana@ecu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH